The contributing role of specific IgE sensitization in the pathophysiology of sinonasal diseases including rhinitis, chronic rhinosinusitis (CRS) 
S
pecific IgE sensitization plays a major contributory role in the pathophysiology of upper and lower respiratory diseases including rhinitis and asthma. Although it is estimated that allergic sensitization to environmental allergens is present in 75% of patients with rhinitis, 1 the role of allergy in chronic rhinosinusitis (CRS) and nasal polyps is less certain. 2 In this article the role of allergy in sinonasal disease is explored, followed by an overview of diagnostic testing tools for determining immediate hypersensitivity.
EPIDEMIOLOGY OF ALLERGIC RHINITIS IN CRS
There exists a high degree of overlap between CRS 3 and allergic rhinitis, 4 but this relationship may be more coincidental than etiologic. 5 Eighty-two percent of patients in an academic institution who underwent sinus surgery were noted to have one or more positive skin-prick test results to inhalant allergens. This was significantly higher than that found in the National Health and Nutrition Examination Study III (54.3%) but comparable with the rhinitis control group (72%) that did not have CRS. 6 Although IgE-mediated hypersensitivity occurs in patients with CRS, the weight of the available evidence suggests that allergic rhinitis contributes in a variable but limited way to the mucosal inflammation of CRS. 2 For example, in a retrospective study of pediatric patients, allergy was shown to be a risk factor for protracted symptoms despite endoscopic sinus surgery; however, there is no evidence to support the theory that failure to address allergy adversely affects the probability of success in sinus surgery. 7 With regard to nasal polyps, the prevalence in a population with allergic rhinitis is comparable with that seen in the normal population 8 ; and allergy does not appear to be a risk factor for the development of nasal polyps. 9, 10 Additionally, the presence of allergy does not correlate with polyp size, symptom scores, grading of severity by CT (Lund-Mackay), or rate of polyp recurrence. 11 However, the presence of atopy in the setting of nasal polyps has been shown to be associated with lower quality of life scores and a higher incidence of asthma. 12 Furthermore, there appears to be some subsets of CRS where IgE sensitization may play a greater role. Among these are patients with severe CRS with nasal polyps (CRSwNPs) 13 who often manifest chronic hyperplastic eosinophilic sinusitis in association with multiple positive skin tests, 5 allergic fungal rhinosinusitis, 14 and patients with local polyclonal IgE in the absence of systemic atopy, the potential etiology of which is discussed in this article. 15 
THEORIES FOR ALLERGIC RHINITIS/CRS PATHOPHYSIOLOGICAL LINKAGE
Discussion is warranted regarding several theories whereby inhalant aeroallergen exposure could drive the inflammatory response when it occurs concomitantly in the nose and sinuses (Table 1) . 5 A "direct aeroallergen reaction" is thought to be unlikely because breathing alone does not drive aeroallergens into the sinuses of patients who have not had their sinus ostia altered by surgery. 5 Except for the CRS subtype known as allergic fungal rhinosinusitis, 14 evidence for "sensitization to colonizing fungi" in the pathogenesis of CRS appears to be limited to playing a role as a disease modifier. 2 There exists greater supporting evidence for a "systemic allergic inflammatory process" involving the local nasal airway, nasal-associated lymphatic tissue, the bone marrow, and the sinuses. Supporting this concept, nasal allergen challenge has been shown to result in inflammatory changes within both the ipsilateral, but strikingly, also the contralateral maxillary sinus cavity, marked by a significant increase in maxillary sinus eosinophils. 16 Finally, the "sensitization to colonizing bacteria" hypothesis proposes that in CRSwNPs, exposure to Staphylococcus aureus enterotoxins, induces an inflammatory mucosal response, resulting in a skewing of T lymphocytes toward a Th2 phenotype, proinflammatory cytokine release, localized polyclonal IgE responses, Treg inhibition, and accentuated eosinophil and mast cell activity. [17] [18] [19] Superantigen-induced polyclonal IgE in airway disease has been postulated to contribute to chronic inflammation by continuously activating mast cells. In studies where tissue fragments from nasal polyp patients were stimulated with anti-IgE, mast cells were activated, indicating that mucosal IgE antibodies in nasal polyp tissue are functional and able to activate mast cells. 20 The polyclonal IgE response may be directed at bystander pathogens 
DIAGNOSTIC TESTING FOR IMMEDIATE HYPERSENSITIVITY
Despite uncertainties regarding the contribution of allergy to CRS, knowledge of specific allergic sensitizations may provide benefit to patients who suffer from associated rhinitis symptoms. The primary tools available to determine the presence of IgE-mediated hypersensitivity 23 include skin tests and in vitro tests for allergen-specific IgE. Although both techniques are able to identify specific IgE-mediated hypersensitivity, skin testing by prick/puncture technique is the preferred diagnostic approach because of its overall sensitivity, specificity, and rapidity of performance. [24] [25] [26] [27] [28] Skin testing detects the presence of allergen-specific IgE bound to mast cells by eliciting allergeninduced mast cell degranulation and a resultant histamine wheal/ flare response. For a detailed description of the skin test procedure, the reader is referred to diagnostic testing practice parameters. 24 Factors that may affect interpretation and reliability of prick/puncture tests include the skill of the tester, the test instruments, extremes of age, skin color, skin reactivity (including dermatographism), and reagent potency. Additionally, concurrent medications affect the validity of skin testing; in particular, first-/second-generation antihistamines and tricyclic antidepressants should be held for 3-7 days depending on the agent, and H 2 -antagonists for 1 day. 24 Although ␤-adrenergic blocking agents do not interfere with the skin test response, caution with their concomitant use is warranted because of the potential of ␤-blockers to impede epinephrine treatment of anaphylaxis, which is a rare but potential adverse reaction of skin testing. 29 Because of this risk, a physician should always be available to administer emergency epinephrine if necessary. [30] [31] [32] Ideally, objective wheal-and-flare responses are recorded in millimeters, along with positive and negative controls. In the clinical setting of strongly suspected hypersensitivity, intracutaneous tests (at 100-to 1000-fold more dilute) may be applied if prick/puncture tests are negative. Intracutaneous tests are associated with increased risk of inducing anaphylaxis, which can be fatal. 33 This is more of a safety concern when/if intracutaneous tests are performed without preceding prick/puncture tests. Interpretation of intracutaneous tests may be confounded by false positive results because of irritant effects of the testing reagent.
Immunoassays measuring serum-specific IgE concentrations (kIU/L) have good sensitivity/specificity and can predict respiratory responses after allergen exposure. 24, 28 These assays provide information that is not equivalent to skin testing but is considered complementary. 34 The clinical efficacy of a total IgE measurement is limited; it is much more valuable to measure serum-specific IgE. There are circumstances when serum-specific IgE immunoassays may be preferable to skin testing such as in the setting of generalized dermatitis, concomitant medications that may suppress the skin test, uncooperative patients, or when the history suggests an unusually greater risk of anaphylaxis from skin testing. 24 Whether by skin testing or in vitro testing, the identification of specific IgE requires clinical correlation with the history and physical exam. 24 In circumstances where the history strongly suggests allergen sensitivity, but testing for specific IgE is negative, a nasal allergen provocation test and/or detection of local nasal specific IgE may confirm the diagnosis. 35 In this condition, referred to as "entopy," local IgE production may be limited to the nasal mucosa in patients who would otherwise be diagnosed as having nonallergic rhinitis. 36, 37 Finally, despite advances in evidence-based medicine, unproven tests continue to be promoted for the determination of allergic sensitization. These include IgG4-specific antibody tests, cytotoxic tests, provocation-neutralization, electrodermal testing, applied kinesiology, iridology, and hair analysis. 38 Currently, there is neither evidence nor an immune/mechanistic basis to suggest that these tests are useful.
SUMMARY
Specific IgE sensitization plays a contributing role in sinonasal disease, particularly in rhinitis, but also to an undetermined and variable extent in CRS and nasal polyps. Although it is estimated that allergic sensitization to environmental allergens is present in 75% of patients with rhinitis, the role of allergic contribution to CRS is less certain. However, when atopy is present in the setting of nasal polyps, it is associated with worse quality of life and a higher incidence of asthma. Several theories have been put forth whereby inhalant aeroallergen exposure could drive the inflammatory response that occurs both in the nose and sinuses. In patients with CRS or nasal polyps, when the history suggests the presence of allergic sensitization, skin testing is the preferred test for the determination of immediate hypersensitivity. In certain clinical settings, in vitro testing for allergenspecific IgE provides an additional diagnostic tool. Finally, a nasal allergen provocation test may confirm the presence of local allergy in the setting of negative skin tests, but its efficacy is limited because of labor intensity and because it is confounded by the potential for false positive results. Whether by skin testing or in vitro testing, the identification of specific IgE sensitization, when clinically correlated with the history and physical exam, allows the clinician to best determine and treat the allergic contribution to sinonasal disease. Once an allergic contribution has been determined, the clinician must weigh the medical evidence as to what therapeutic interventions, including immunotherapy, 39 are appropriate.
CLINICAL PEARLS
• Although specific IgE sensitization can be determined by in vitro assay, prick/puncture skin test technique provides more rapid results, which, unlike in vitro tests, are not influenced by high total IgE levels.
• Interpretation of skin testing may be confounded by extremes of age, skin color, dermatographism, and antihistamine use.
• Interpretation of skin testing should be performed by an experienced practitioner, in the presence of positive and negative controls.
• Because skin testing may potentially result in anaphylaxis, a physician should always be available to administer epinephrine if necessary.
• Whether by skin testing or in vitro testing, the identification of specific IgE requires clinical correlation with the history and physical exam to make the diagnosis of allergy.
• In a condition known as entopy, specific IgE sensitization can only be identified in the nasal mucosa and can not be found systemically. 
